Drug developers Moderna Thursday filed for clearance from the US Food and Drug Administration (FDA) to extend the use of their COVID-19 vaccine to children aged 6 months to 5 years, it was announced.

The Food and Drug Administration on Thursday approved the new Covid vaccine from Pfizer and Moderna. It’s the third time the vaccines have been updated to match circulating strains since the ...

Moderna Inc's coronavirus vaccine on Friday became the second to receive emergency use authorization (EUA) from the U.S. Food and Drug Administration, welcome news to a nation with a staggering ...

Moderna has secured FDA approval for its respiratory syncytial virus (RSV) vaccine, giving it a chance to generate revenue from a second product as sales of its Spikevax COVID-19 shot have slumped.

Currently, Moderna boosters have only been approved for certain people with weakened immune systems, such as cancer patients or transplant recipients. FDA Ruling: The FDA approved people 65 and ...

The FDA is looking to quickly approve Moderna ... around -75C required to maintain the integrity of its already-approved rival. Moderna’s vaccine is also given in two shots, with the injections ...

A second coronavirus vaccine is nearing emergency approval in the ... the panel's endorsement, FDA commissioner Stephen Hahn said his agency had informed Moderna it would work "rapidly" towards ...

Unrestricted access to all Essential and Insights content Access to the PRWeek Consultancy Tracker and the Top 150 Monthly Trading Tracker Hub In-depth reports including quarterly and annual ...

Opinions expressed by Forbes Contributors are their own. Randy Bean is a noted Senior Advisor, Author, Speaker, Founder, & CEO. While the application of data and AI holds the potential to ...

Moderna has received Health Canada's approval for its respiratory syncytial virus messenger ribonucleic acid (mRNA) vaccine mRESVIA, designed to prevent lower respiratory tract disease (LRTD ...